Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.

Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNon-significant updates to page metadata were applied: clarifications that publications are provided voluntarily by the study entry staff and are auto-filled from PubMed, plus new time-related fields such as 'Results First Posted (Estimated)' and 'Last Update Posted (Estimated)' and the Revision version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check17 days agoChange DetectedResults for LEAP-005 have been posted, including ORR, DCR, PFS, and OS outcomes with definitions and time frames. The page now lists a non-randomized design and updated trial sites such as Tainan, Taiwan.SummaryDifference2%

- Check32 days agoChange DetectedPublications with LEAP-005 results were added to the Study Results section, including outcomes for the triple-negative breast cancer and ovarian cancer cohorts.SummaryDifference0.2%

- Check39 days agoChange DetectedReplaced the Santiago de Cali site entry with Cali, Valle del Cauca Department, Colombia, 760032 and added this Cali site to the study locations.SummaryDifference0.0%

- Check53 days agoChange DetectedUpdated status: from 'No Results Posted' to 'Results Submitted', indicating that results have now been submitted.SummaryDifference0.1%

- Check60 days agoChange DetectedCore content updated with a government-operating-status notice and a new version tag (v3.2.0); the old version v3.1.0 was removed.SummaryDifference1%

Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.